chloroquine and abt-737

chloroquine has been researched along with abt-737 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dobromilskaya, I; Gardner, EE; Hann, CL; Marchionni, L; Murphy, S; Rudin, CM; Zinn, RL1
Chen, F; Jia, J; Li, J; Song, Y; Yin, P; Zhang, Y1

Other Studies

2 other study(ies) available for chloroquine and abt-737

ArticleYear
Combination treatment with ABT-737 and chloroquine in preclinical models of small cell lung cancer.
    Molecular cancer, 2013, Mar-02, Volume: 12

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Biphenyl Compounds; Cell Proliferation; Cell Survival; Chloroquine; Drug Resistance, Neoplasm; Female; Gene Knockdown Techniques; Humans; Lung Neoplasms; Membrane Proteins; Mice; Mice, Nude; Nitrophenols; Piperazines; RNA, Small Interfering; Small Cell Lung Carcinoma; Sulfonamides; Tumor Burden; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2013
ABT-737, a Bcl-2 Selective Inhibitor, and Chloroquine Synergistically Kill Renal Cancer Cells.
    Oncology research, 2016, Volume: 24, Issue:1

    Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Biphenyl Compounds; Carcinoma, Renal Cell; Cell Death; Cell Line, Tumor; Chloroquine; Drug Synergism; Humans; Kidney Neoplasms; Leucine; Nitrophenols; Oligopeptides; Piperazines; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Thiadiazoles

2016